Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription Articles published in Br J Ophthalmol Retrieve available abstracts of 29 articles: HTML format

Single Articles

June 2026
1. VIGGIANO P, Peto T, Pignataro M, Termite AC, et al
   Proactive treatment regimen with dexamethasone implant for diabetic and post-occlusive macular oedema: the ProDEX-2 study.
   Br J Ophthalmol. 2026 Jun 5:bjo-2025-328550. doi: 10.1136/bjo-2025-328550.
   PubMed     Abstract available
   
   
   
2. KHALID H, Tsai WS, Lamanna F, Riotto E, et al
   Quantification of retinal non-perfusion in eyes with diabetic retinopathy to study the association with retinal neovascularisation: INSPIRED study report 3.
   Br J Ophthalmol. 2026 Jun 4:bjo-2025-329361. doi: 10.1136/bjo-2025-329361.
   PubMed     Abstract available
   
   
   May 2026
3. CAO D, Tan R, Goh RA, Yang Q, et al
   Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progression: a 2-year longitudinal study in Asians.
   Br J Ophthalmol. 2026 May 12:bjo-2025-327940. doi: 10.1136/bjo-2025-327940.
   PubMed     Abstract available
   
   
   
4. FRASER-BELL S, Lee NS, Hashimoto Y, Pollreisz A, et al
   Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.
   Br J Ophthalmol. 2026 May 6:bjo-2025-328621. doi: 10.1136/bjo-2025-328621.
   PubMed     Abstract available
   
   
   
5. RUIZ BILBAO S, Mas Casals A, Gomez Sanchez S, Diaz-Aljaro P, et al
   Cost-effectiveness of OCT-enhanced screening for diabetic retinopathy: a 50-year Markov model analysis in type 2 diabetes.
   Br J Ophthalmol. 2026 May 5:bjo-2025-327884. doi: 10.1136/bjo-2025-327884.
   PubMed     Abstract available
   
   
   April 2026
6. CHALKIADAKI E, Sim YS, Williams O, Elder L, et al
   Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema.
   Br J Ophthalmol. 2026 Apr 21:bjo-2025-328893. doi: 10.1136/bjo-2025-328893.
   PubMed     Abstract available
   
   
   
7. LIU Y, Huang J, Ao M, Huang Y, et al
   Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study.
   Br J Ophthalmol. 2026 Apr 15:bjo-2025-329066. doi: 10.1136/bjo-2025-329066.
   PubMed     Abstract available
   
   
   January 2026
8. FRANQUESA-GARCIA F, Romero-Nunez B, Martin-Pinardel R, De Zanet S, et al
   Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project.
   Br J Ophthalmol. 2026 Jan 16:bjo-2025-328172. doi: 10.1136/bjo-2025-328172.
   PubMed     Abstract available
   
   
   November 2025
9. CHOE S, Xi C, Park DY, Kang KH, et al
   Synergistic effects of glaucoma, degeneration of macula and posterior pole, and diabetic ophthalmic complications on vision loss.
   Br J Ophthalmol. 2025 Nov 17:bjo-2025-327643. doi: 10.1136/bjo-2025-327643.
   PubMed     Abstract available
   
   
   October 2025
10. XU X, Zhang J, Song X, Liu X, et al
    Enhancing diabetic retinopathy diagnosis and grading: a retrospective study on AI-assisted decision making and cost analysis.
    Br J Ophthalmol. 2025 Oct 20:bjo-2025-327442. doi: 10.1136/bjo-2025-327442.
    PubMed     Abstract available
    
    
    August 2025
11. JOSEPH S, Wang Y, Drinkwater JJ, Jan CL, et al
    Effectiveness of artificial intelligence-based diabetic retinopathy screening in primary care and endocrinology settings in Australia: a pragmatic trial.
    Br J Ophthalmol. 2025 Aug 22:bjo-2025-327447. doi: 10.1136/bjo-2025-327447.
    PubMed     Abstract available
    
    
    July 2025
12. KIM SJ, Gangaputra S, Sheng J, Patel S, et al
    Analysis of 24 pro-inflammatory cytokines in aqueous and serum of 94 patients without diabetes.
    Br J Ophthalmol. 2025 Jul 22:bjo-2025-327421. doi: 10.1136/bjo-2025-327421.
    PubMed     Abstract available
    
    
    
13. HASHIMOTO Y, Hunt AR, Silva R, Witmer A, et al
    Differentiating treatment episodes from gaps in eyes with diabetic macular oedema.
    Br J Ophthalmol. 2025 Jul 1:bjo-2025-327238. doi: 10.1136/bjo-2025-327238.
    PubMed     Abstract available
    
    
    June 2025
14. WU H, Su Z, Pan X, Shao A, et al
    Enhancing diabetic retinopathy query responses: assessing large language model in ophthalmology.
    Br J Ophthalmol. 2025 Jun 30:bjo-2024-325861. doi: 10.1136/bjo-2024-325861.
    PubMed     Abstract available
    
    
    
15. PANDEY PU, Micieli JA, Ong Tone S, Eng KT, et al
    Realistic fundus photograph generation for improving automated disease classification.
    Br J Ophthalmol. 2025;109:791-798.
    PubMed     Abstract available
    
    
    May 2025
16. RUIZ-MEDRANO J, Udaondo Mirete P, Fernandez-Jimenez M, Asencio-Duran M, et al
    Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study.
    Br J Ophthalmol. 2025 May 16:bjo-2024-325665. doi: 10.1136/bjo-2024-325665.
    PubMed     Abstract available
    
    
    
17. LIU Z, Huang Y, Jin L, Pan C, et al
    Validation of a self-administered Home ETDRS visual acuity testing (H-ETDRS) for self-monitoring vision changes in retinal diseases.
    Br J Ophthalmol. 2025 May 10:bjo-2024-326283. doi: 10.1136/bjo-2024-326283.
    PubMed     Abstract available
    
    
    March 2025
18. LEE WA, Shao SC, Hsieh MH, Liao TC, et al
    Adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema in Taiwan: a comparative cohort study.
    Br J Ophthalmol. 2025 Mar 27:bjo-2024-325509. doi: 10.1136/bjo-2024-325509.
    PubMed     Abstract available
    
    
    
19. ZHANG W, Cheng S, Gu X, Liu X, et al
    Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial.
    Br J Ophthalmol. 2025 Mar 23:bjo-2024-326006. doi: 10.1136/bjo-2024-326006.
    PubMed     Abstract available
    
    
    February 2025
20. DANIELI L, Midena G, Frizziero L, Midena E, et al
    Disorganisation of inner retinal layers in diabetic macular oedema: is it time to standardise this OCT biomarker?
    Br J Ophthalmol. 2025 Feb 27:bjo-2024-326843. doi: 10.1136/bjo-2024-326843.
    PubMed     Abstract available
    
    
    
21. CAO J, Su T, Chen S, Du Z, et al
    Evaluating lipid-lowering drug targets for full-course diabetic retinopathy.
    Br J Ophthalmol. 2025 Feb 3:bjo-2024-325771. doi: 10.1136/bjo-2024-325771.
    PubMed     Abstract available
    
    
    November 2024
22. PARIS A, Volpe G, Perruchoud-Ader K, Casanova A, et al
    Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.
    Br J Ophthalmol. 2024 Nov 12:bjo-2024-326053. doi: 10.1136/bjo-2024-326053.
    PubMed     Abstract available
    
    
    August 2024
23. ZHONG X, Yang S, Zhu Z, Li H, et al
    Trajectories of choriocapillaris perfusion in healthy individuals and patients with diabetes mellitus: a prospective cohort study.
    Br J Ophthalmol. 2024 Aug 28:bjo-2024-325515. doi: 10.1136/bjo-2024-325515.
    PubMed     Abstract available
    
    
    May 2024
24. ZHONG P, Yang S, Liu R, Zhu Z, et al
    Handgrip strength and risks of diabetic vascular complications: Evidence from Guangzhou Diabetic Eye Study and UK cohorts.
    Br J Ophthalmol. 2024 May 30:bjo-2023-324893. doi: 10.1136/bjo-2023-324893.
    PubMed     Abstract available
    
    
    
25. BRESSLER I, Aviv R, Margalit D, Rom Y, et al
    Autonomous screening for laser photocoagulation in fundus images using deep learning.
    Br J Ophthalmol. 2024;108:742-746.
    PubMed     Abstract available
    
    
    
26. JIN G, Ma Y, Zheng D, Jin L, et al
    Evaluation of systemic medications associated with diabetic retinopathy: a nested case-control study from the UK Biobank.
    Br J Ophthalmol. 2024 May 20:bjo-2023-324930. doi: 10.1136/bjo-2023-324930.
    PubMed     Abstract available
    
    
    
27. CHEONG KX, Zhang C, Tan TE, Fenner BJ, et al
    Comparing generative and retrieval-based chatbots in answering patient questions regarding age-related macular degeneration and diabetic retinopathy.
    Br J Ophthalmol. 2024 May 15:bjo-2023-324533. doi: 10.1136/bjo-2023-324533.
    PubMed     Abstract available
    
    
    
28. VINGOPOULOS F, Baldwin G, Katz R, Cui Y, et al
    Associations of quantitative contrast sensitivity with vascular metrics on widefield swept-source OCT angiography across stages of diabetic retinopathy.
    Br J Ophthalmol. 2024 May 6:bjo-2023-323900. doi: 10.1136/bjo-2023-323900.
    PubMed     Abstract available
    
    
    February 2024
29. MELLOR J, Jiang W, Fleming A, McGurnaghan SJ, et al
    Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme.
    Br J Ophthalmol. 2024 Feb 5:bjo-2023-323400. doi: 10.1136/bjo-2023-323400.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum